FDA Class II · Drug · August 19, 2026
TADALAFIL USP recall — Shoolin Pharma Chem LLP
CGMP Deviations:Noted during FDA inspection
Company / brand: Shoolin Pharma Chem LLP
Affected product: TADALAFIL USP
Official ID D-0760-2026 · Official record ↗
TADALAFIL USP: recall status
⚠ Recalls found. TADALAFIL USP is named in 3 official recalls in our current data:
- FDA Class II recall D-0760-2026 — CGMP Deviations:Noted during FDA inspection
- FDA Class II recall D-0761-2026 — CGMP Deviations:Noted during FDA inspection
- FDA Class II recall D-0762-2026 — CGMP Deviations:Noted during FDA inspection
Recalls naming this model
FDA Class II · Drug · August 19, 2026
TADALAFIL USP recall — Shoolin Pharma Chem LLP
CGMP Deviations:Noted during FDA inspection
Company / brand: Shoolin Pharma Chem LLP
Affected product: TADALAFIL USP
Official ID D-0761-2026 · Official record ↗
FDA Class II · Drug · August 19, 2026
TADALAFIL USP recall — Shoolin Pharma Chem LLP
CGMP Deviations:Noted during FDA inspection
Company / brand: Shoolin Pharma Chem LLP
Affected product: TADALAFIL USP
Official ID D-0762-2026 · Official record ↗
See all Shoolin Pharma Chem LLP recalls →
Verify with the official sources:
- CPSC — consumer products ↗ (aggregated here)
- NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
- FDA — food, drugs, medical devices ↗ (aggregated here)
- USDA FSIS — meat, poultry & processed egg products ↗ (not aggregated here)
- Recalls.gov — the U.S. government’s all-agency portal ↗
Found something wrong or missing? Report a data error.
Compiled from connected official public-domain government data. Sources last checked September 7, 2026 at 6:00 AM UTC.